[Optimal duration of dual antiplatelet therapy]

Semergen. 2015 Nov-Dec;41(8):448-9. doi: 10.1016/j.semerg.2015.04.017. Epub 2015 Jul 4.

[Article in Spanish]

Authors

C Escobar¹, J A Divison²

Affiliations

¹ Servicio de Cardiología, Hospital Universitario La Paz, Grupo de hipertensión arterial de SEMERGEN, Madrid, España. Electronic address: [email protected].
² Profesor Facultad de Medicina UCAM, Grupo de hipertensión arterial de SEMERGEN, Murcia, España.

PMID: 26149057
DOI: 10.1016/j.semerg.2015.04.017

No abstract available

Publication types

Comment

MeSH terms

Aspirin*
Drug Therapy, Combination
Humans
Platelet Aggregation Inhibitors / therapeutic use*

Substances

Platelet Aggregation Inhibitors
Aspirin